Virax Biolabs Group Limited
Hedge Funds Holdings
Last updated:
Virax Biolabs Group Limited‘s stocks are currently a part of 2 hedge funds’ portfolios, which represents 0.73% of the total amount of its stocks outstanding. This makes up a total of 18.69K shares of Virax Biolabs Group Limited. Compared to the previous quarter, the number fell by -89.89% or -166.20K shares fewer. As for the holding position changes, 50% (1) of current holders sold a part of the shares held, and 150% (3) closed the holdings completely. 1 hedge funds are new holders of Virax Biolabs Group Limited stock in Q1 2023, it is 50% of total holders.
Hedge funds holding Virax Biolabs Group Limited (Q3 2022 – Q1 2023)
| Q3 2022 | 4 |
|---|---|
| Q4 2022 | 7 |
| Q1 2023 | 2 |
Hedge funds changes in Virax Biolabs Group Limited positions (Q3 2022 – Q1 2023)
| Q3 2022 | 4 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2022 | 6 | 0 | 1 | 3 | -3 |
| Q1 2023 | 1 | 0 | 1 | 3 | -3 |
Top 50 hedge fund holders of Virax Biolabs Group Limited (NASDAQ:VRAX)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| SCHONFELD STRATEGIC ADVISORS LLC | 115K | 36.6K | 0.001% |
| UBS GROUP AG | 38K | 12.19K | 0.000% |
| BANK OF AMERICA CORP /DE/ | 28K | 8.92K | 0.000% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 2K | 649 | 0.000% |